Login / Signup

TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.

Julien DreyfusXavier GallooMaurizio TaramassoGregor HeitzingerGiovanni BenfariKarl-Patrick KresojaFernando Juarez-CassoHazem OmranYohann BohbotChristos IliadisGiulio RussoYan TopilskyMarcel WeberLuis Nombela-FrancoAlessandra SalaAndrea Eixerés-EsteveBernard IungJean-François ObadiaRodrigo Estevez LoureiroElisabeth RiantErwan DonalJörg HausleiterLuigi BadanoThierry Le TourneauAugustin CoisneThomas ModineAzeem LatibFabien PrazStephan WindeckerJose Luis ZamoranoRalph Stephan von BardelebenGilbert H L TangRebecca HahnJohn WebbDenisa MuraruMohammed NejjariVincent ChanMichele De BonisManuel Carnero AlcazarGeorg NickenigRoman PfisterChristophe TribouilloyVolker RudolphJuan CrestanelloPhilipp LurzPhilipp BartkoFrancesco MaisanoJeroen BaxMaurice Enriquez-SaranoDavid Messika-Zeitounnull null
Published in: European heart journal (2023)
Survival progressively decreased with the TRI-SCORE irrespective of treatment modality. Compared to conservative management, an early and successful surgical or transcatheter intervention improved 2-year survival in patients at low and, to a lower extent, intermediate TRI-SCORE, while no benefit was observed in the high TRI-SCORE category.
Keyphrases
  • randomized controlled trial
  • end stage renal disease
  • ejection fraction
  • aortic valve
  • chronic kidney disease
  • newly diagnosed
  • aortic stenosis
  • early onset
  • heart failure
  • coronary artery disease
  • left ventricular